Gain-of-function and loss-of-function variants in GRIA3 lead to distinct neurodevelopmental phenotypes
- 1 December 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 147 (5) , 1837-1855
Abstract
AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors (AMPARs) mediate fast excitatory neurotransmission in the brain. AMPARs form by homo- or heteromeric assembly of subunits encoded by the GRIA1-GRIA4 genes, of which only GRIA3 is X-chromosomal. Increasing numbers of GRIA3 missense variants are reported in patients with neurodevelopmental disorders (NDD), but only a few have been examined functionally. Here, we evaluated the impact on AMPAR function of one frameshift and 43 rare missense GRIA3 variants identified in patients with NDD by electrophysiological assays. Thirty-one variants alter receptor function and show loss-of-function (LoF) or gain-of-function (GoF) properties, whereas 13 appeared neutral. We collected detailed clinical data from 25 patients (from 23 families) harbouring 17 of these variants. All patients had global developmental impairment, mostly moderate (9/25) or severe (12/25). Twelve patients had seizures, including focal motor (6/12), unknown onset motor (4/12), focal impaired awareness (1/12), (atypical) absence (2/12), myoclonic (5/12), and generalized tonic-clonic (1/12) or atonic (1/12) seizures. The epilepsy syndrome was classified as developmental and epileptic encephalopathy in eight patients, developmental encephalopathy without seizures in 13 patients, and intellectual disability with epilepsy in four patients. Limb muscular hypotonia was reported in 13/25, and hypertonia in 10/25. Movement disorders were reported in 14/25, with hyperekplexia or non-epileptic erratic myoclonus being the most prevalent feature (8/25). Correlating receptor functional phenotype with clinical features revealed clinical features for GRIA3-associated NDDs and distinct NDD phenotypes for LoF and GoF variants. GoF variants were associated with more severe outcomes: patients were younger at the time of seizure onset (median age one month), hypertonic, and more often had movement disorders, including hyperekplexia. Patients with LoF variants were older at the time of seizure onset (median age 16 months), hypotonic, and had sleeping disturbances. LoF and GoF variants were disease-causing in both sexes but affected males often carried de novo or hemizygous LoF variants inherited from healthy mothers, whereas all but one affected females had de novo heterozygous GoF variants.Keywords
Funding Information
- Novo Nordisk Foundation (NNF20SA0064340)
- National Natural Science Foundation of China (32200779)
- National Institutes of Health (5U54OD030165)
- National Key R & D Program of China (2019YFA0801603, 32170951)
- Fundamental Research Funds for the Central Universities (021414380533)
- Special Fund for Science and Technology Innovation Strategy of Guangdong Province (2021B0909050004)
- Independent Research Fund Denmark (3101-00386B)
This publication has 102 references indexed in Scilit:
- Movement Disorders in GRIA2‐Related Disorder – Expanding the Genetic Spectrum of Developmental Dyskinetic EncephalopathyMovement Disorders Clinical Practice, 2023
- SCN1A variants from bench to bedside—improved clinical prediction from functional characterizationHuman Mutation, 2019
- Assessment of patient clinical descriptions and pathogenic variants from gene panel sequences in the CAGI‐5 intellectual disability challengeHuman Mutation, 2019
- GeneMatcher: A Matching Tool for Connecting Investigators with an Interest in the Same GeneHuman Mutation, 2015
- Molecular Findings Among Patients Referred for Clinical Whole-Exome SequencingJAMA, 2014
- Xq25 duplications encompassing GRIA3 and STAG2 genes in two families convey recognizable X‐linked intellectual disability with distinctive facial appearanceAmerican Journal of Medical Genetics Part A, 2013
- Recurrent Rearrangements in Synaptic and Neurodevelopmental Genes and Shared Biologic Pathways in Schizophrenia, Autism, and Mental RetardationArchives of General Psychiatry, 2009
- Aberrant GRIA3 transcripts with multi‐exon duplications in a family with X‐linked mental retardationAmerican Journal of Medical Genetics Part A, 2009
- Partial tandem duplication of GRIA3 in a male with mental retardationAmerican Journal of Medical Genetics Part A, 2007
- The activation of glutamate receptors by kainic acid and domoic acidNatural Toxins, 1998